Venbio Partners is based out of San Francisco. Venbio Partners is a registered investment advisory firm with discretionary assets under management (AUM) of $0 (Form ADV from 2020-03-18). Their last reported 13F filing for Q3 2020 included $658,029,000 in managed 13F securities and a top 10 holdings concentration of 100.0%. Venbio Partners's largest holding is ALX Oncology Holdings Inc. with shares held of 9,699,925. Whalewisdom has at least 17 13F filings
: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
You are limited to the prior 8 quarters of 13F filings. Subscribe to WhaleWisdom to view all filing data for VENBIO PARTNERS LLC
Top 20 equal-weighted holdings. Performance numbers calculated through 2020-11-16
|Performance for Q3 2020:||11.04%|
|Performance Last 4 Quarters:||10.3%|
|SEC Registration as :|
|Form of Organization:||Limited Liability Company|
|Number of employees:|
|Other Business Activities:|
|Amount of client funds and securities:|
|Total Number of Clients:||0|
|Amount of client funds and securities by related persons:|
|Total Number of clients from related persons:|